Azitra, Inc.
Related Filers (28)
- Whitfill Travis (4)
- Bios Equity Partners, LP (3)
- Salva Francisco D. (3)
- McClary Andrew (3)
- BAYER HEALTHCARE LLC (3)
- Staskey Norm (3)
- Fletcher Aaron G.L. (2)
- Cavu Management, LP (2)
- BIOS Advisors GP, LLC (2)
- BIOS Azitra Co-Invest I, LP (2)
- Kreis Leslie W. (2)
- BIOS Fund I, LP (2)
- BIOS Fund II QP, LP (2)
- BIOS Equity Partners III, LP (2)
- BIOS Fund I QP, LP (2)
- Cavu Advisors, LLC (2)
- BIOS Fund III, LP (2)
- BIOS Fund II NT, LP (2)
- BIOS Fund III QP, LP (2)
- BIOS Capital Management, LP (2)
- BIOS Fund II, LP (2)
- Bios Equity Partners II, LP (2)
- BIOS Fund III NT, LP (2)
- BAYER AKTIENGESELLSCHAFT (2)
- Bayer World Investments B.V. (2)
- Bayer US Holding LP (2)
- Ryan Barbara (2)
- Schroer John R. (2)
- Show More ...
Financials (2)
10-Q
Tuesday, 11/14/2023
Quarterly Report for period ending 2023-09-30
10-Q
Monday, 8/14/2023
Quarterly Report for period ending 2023-06-30
News (6)
8-K
Wednesday, 2/14/2024
Current report filing
8-K
Tuesday, 11/14/2023
Current report filing
8-K
Monday, 8/14/2023
Current report filing
8-K
Tuesday, 7/11/2023
Current report filing
8-K
Friday, 7/7/2023
Current report filing
8-K
Wednesday, 6/21/2023
Current report filing
Other (25)
EFFECT
Tuesday, 2/13/2024
Notice of Effectiveness
EFFECT
Thursday, 6/15/2023
Notice of Effectiveness
CORRESP
Tuesday, 6/13/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Tuesday, 6/13/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Tuesday, 6/13/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Wednesday, 5/31/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Tuesday, 5/30/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Tuesday, 5/30/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 5/26/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Monday, 5/22/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Monday, 5/22/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Wednesday, 5/17/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CERT
Wednesday, 5/17/2023
Certification by an exchange approving securities for listing
8-A12B
Tuesday, 5/16/2023
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
CORRESP
Monday, 5/15/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Monday, 5/15/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Monday, 4/10/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Monday, 3/20/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Tuesday, 2/21/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
D
Wednesday, 10/12/2022
Exempt (Private) Offering
D
Tuesday, 1/19/2021
Exempt (Private) Offering
D
Thursday, 9/24/2020
Exempt (Private) Offering
D
Friday, 3/1/2019
Exempt (Private) Offering
D
Thursday, 4/26/2018
Exempt (Private) Offering
D
Monday, 3/20/2017
Exempt (Private) Offering
Ownership (25)
4
Thursday, 2/15/2024
Staskey Norm: Statement of changes in beneficial ownership of securities
4
Thursday, 2/15/2024
Salva Francisco D.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/15/2024
Whitfill Travis: Statement of changes in beneficial ownership of securities
SC 13G
Monday, 2/12/2024
BAYER HEALTHCARE LLC: Major Shareholders
4
Tuesday, 10/3/2023
Staskey Norm: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/3/2023
Schroer John R.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/3/2023
Whitfill Travis: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/3/2023
Ryan Barbara: Statement of changes in beneficial ownership of securities
4
Monday, 7/24/2023
BAYER AKTIENGESELLSCHAFT: Statement of changes in beneficial ownership of securities
3
Monday, 7/24/2023
BAYER AKTIENGESELLSCHAFT: Initial statement of beneficial ownership of securities
SC 13D
Monday, 7/3/2023
Bios Equity Partners, LP: Major Shareholders
4/A
Thursday, 6/29/2023
McClary Andrew: Statement of changes in beneficial ownership of securities
4
Monday, 6/26/2023
McClary Andrew: Statement of changes in beneficial ownership of securities
4
Friday, 6/23/2023
Whitfill Travis: Statement of changes in beneficial ownership of securities
4
Friday, 6/23/2023
BIOS Fund I, LP: Statement of changes in beneficial ownership of securities
4
Friday, 6/23/2023
Salva Francisco D.: Statement of changes in beneficial ownership of securities
4
Friday, 6/23/2023
BIOS Fund III QP, LP: Statement of changes in beneficial ownership of securities
3
Thursday, 6/15/2023
McClary Andrew: Initial statement of beneficial ownership of securities
3
Thursday, 6/15/2023
Ryan Barbara: Initial statement of beneficial ownership of securities
3
Thursday, 6/15/2023
BIOS Fund III QP, LP: Initial statement of beneficial ownership of securities
3
Thursday, 6/15/2023
Salva Francisco D.: Initial statement of beneficial ownership of securities
3
Thursday, 6/15/2023
Schroer John R.: Initial statement of beneficial ownership of securities
3
Thursday, 6/15/2023
Whitfill Travis: Initial statement of beneficial ownership of securities
3
Thursday, 6/15/2023
Staskey Norm: Initial statement of beneficial ownership of securities
3
Thursday, 6/15/2023
BIOS Fund I, LP: Initial statement of beneficial ownership of securities
Prospectus (18)
424B5
Thursday, 2/15/2024
Prospectus filed pursuant to Rule 424(b)(5)
FWP
Friday, 1/19/2024
Filing under Securities Act Rules 163/433 of free writing prospectuses
S-1
Friday, 1/19/2024
General form of registration statement for all companies including face-amount certificate companies
DRS
Thursday, 1/4/2024
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
S-8
Monday, 12/4/2023
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B4
Wednesday, 6/21/2023
Prospectus filed pursuant to Rule 424(b)(4)
S-1/A
Tuesday, 6/13/2023
General form of registration statement for all companies including face-amount certificate companies
FWP
Monday, 6/5/2023
Filing under Securities Act Rules 163/433 of free writing prospectuses
S-1/A
Monday, 6/5/2023
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Tuesday, 5/16/2023
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Tuesday, 5/9/2023
General form of registration statement for all companies including face-amount certificate companies
FWP
Friday, 4/28/2023
Filing under Securities Act Rules 163/433 of free writing prospectuses
FWP
Tuesday, 4/11/2023
Filing under Securities Act Rules 163/433 of free writing prospectuses
S-1/A
Monday, 4/10/2023
General form of registration statement for all companies including face-amount certificate companies
FWP
Monday, 3/27/2023
Filing under Securities Act Rules 163/433 of free writing prospectuses
S-1/A
Monday, 3/20/2023
General form of registration statement for all companies including face-amount certificate companies
S-1
Tuesday, 2/21/2023
General form of registration statement for all companies including face-amount certificate companies
DRS
Thursday, 12/15/2022
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy